Tigecycline treatment experience against multidrug-resistant Acinetobacter baumannii infections: a systematic review and meta-analysis
- 1 February 2016
- journal article
- research article
- Published by Elsevier BV in International Journal of Antimicrobial Agents
- Vol. 47 (2), 107-116
- https://doi.org/10.1016/j.ijantimicag.2015.11.011
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Efficacy and safety of tigecycline for the treatment of severe infectious diseases: an updated meta-analysis of RCTsInternational Journal of Infectious Diseases, 2015
- Global Assessment of Antimicrobial Susceptibility among Gram-Negative Organisms Collected from Pediatric Patients between 2004 and 2012: Results from the Tigecycline Evaluation and Surveillance TrialJournal of Clinical Microbiology, 2015
- In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumanniiThe Journal of Antibiotics, 2013
- Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysisThe Lancet Infectious Diseases, 2011
- Efficacy and safety of tigecycline: a systematic review and meta-analysisJournal of Antimicrobial Chemotherapy, 2011
- Systematic Review and Meta-Analysis of the Effectiveness and Safety of Tigecycline for Treatment of Infectious DiseaseAntimicrobial Agents and Chemotherapy, 2011
- Off-label use of antibiotics in hospitalized patients: focus on tigecyclineJournal of Antimicrobial Chemotherapy, 2009
- Indications of a new antibiotic in clinical practice: results of the tigecycline initial use registry.The Brazilian Journal of Infectious Diseases, 2008
- Global Challenge of Multidrug-ResistantAcinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2007
- Tigecycline: a novel glycylcycline antibioticExpert Review of Anti-infective Therapy, 2006